Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Return on Equity [ROE] (2018 - 2026)

Updated

Crinetics Pharmaceuticals' Return on Equity [ROE] came in at -40.51% for Q2 2026, down 45.05 percentage points from 4.53% a year earlier and down 17.21 percentage points from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Crinetics Pharmaceuticals' Return on Equity [ROE] was -40.17%, down 8.20 percentage points from FY2024.

  • Return on Equity [ROE] carries a five-year change of +11.44 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -31.97% in FY2024 (+16.97 pp), -48.94% in FY2023 (-99.20 pp), 50.26% in FY2022 (+93.24 pp) and -42.98% in FY2021 (+8.62 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q4 2021.
  • Year-over-year, Return on Equity [ROE] has declined for three consecutive quarters, with an average year-over-year change of -4.05 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2023 (a gain of 92.22 percentage points), and the weakest in Q2 2024 (a drop of 88.25 percentage points).
  • Business Quant data shows CRNX's Return on Equity [ROE] at -23.30% (Q1 2026), -3.91% (Q4 2025) and 0.15% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn -40.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -40.51%
Mar 31, 2026 -23.30%
Dec 31, 2025 -3.91%
Sep 30, 2025 0.15%
Jun 30, 2025 4.53%
Mar 31, 2025 1.04%
Dec 31, 2024 -1.57%
Sep 30, 2024 -35.95%
Jun 30, 2024 -19.44%
Mar 31, 2024 -26.71%
Dec 31, 2023 -38.52%
Sep 30, 2023 49.49%
Jun 30, 2023 68.82%
Mar 31, 2023 58.76%
Dec 31, 2022 48.80%
Sep 30, 2022 -18.05%
Jun 30, 2022 -23.40%
Mar 31, 2022 -30.53%
Dec 31, 2021 -40.96%
Sep 30, 2021 27.90%
API Access

Crinetics Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRNX&period=max&api_key=YOUR_API_KEY